Primary endocrine tumours of the liver

British Journal of Surgery

Volumn 92, Issue 10, 2005, Pages 1255-1260

  Maire, F ^a   Couvelard, A ^a   Vullierme, M P ^a   Kianmanesh, R ^a   O'Toole, D ^a   Hammel, P ^a   Belghiti, J ^a   Ruszniewski, P ^a  

^a BEAUJON HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOSTATIN RECEPTOR; ANTINEOPLASTIC AGENT;

ABDOMINAL RADIOGRAPHY; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER SURGERY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ENDOCRINE TUMOR; FEMALE; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL TRACT SCINTISCANNING; HUMAN; LIVER TUMOR; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; THORAX RADIOGRAPHY; TREATMENT OUTCOME; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; SURVIVAL;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ENDOCRINE GLAND NEOPLASMS; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 26944447922     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.5073     Document Type: Article

References (38)

1. Kulke MH, Mayer RJ. Carcinoid tumors. N Engl J Med 1999; 340: 858-868.
2. Perrier ND, Batts KP, Thompson GB, Grant CS, Plummer TB. An immunohistochemical survey for neuroendocrine cells in regional pancreatic lymph nodes: a plausible explanation for primary nodal gastrinomas? Mayo Clinic Pancreatic Surgery Group. Surgery 1995; 118: 957-965.
3. Jensen RT. Carcinoid and pancreatic endocrine tumors: recent advances in molecular pathogenesis, localization, and treatment. Curr Opin Oncol 2000; 12: 368-377.
4. Weber HC, Venzon DJ, Lin JT, Orbuch M, Strader DB, Gibril F et al. Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term study. Gastroenterology 1995; 108: 1637-1649.
5. Yu F, Venzon DJ, Serrano J, Goebel SU, Doppman JL, Gibril F et al. Prospective study of the clinical course, prognostic factors, causes of death, and survival in patients with long-standing Zollinger-Ellison syndrome. J Clin Oncol 1999; 17: 615-630.
6. Madeira I, Terris B, Voss M, Denys A, Sauvanet A, Flejou JF et al. Prognostic factors in patients with endocrine tumours of the duodenopancreatic area. Gut 1998; 43: 422-427.
7. Ruckert RI, Ruckert JC, Dorffel Y, Rudolph B, Muller JM. Primary hepatic neuroendocrine tumor: successful hepatectomy in two cases and review of the literature. Digestion 1999; 60: 110-116.
8. Iwao M, Nakamuta M, Enjoji M, Kubo H, Fukutomi T, Tanabe Y et al. Primary hepatic carcinoid tumor: case report and review of 53 cases. Med Sci Monit 2001; 7: 746-750.
9. Fukunaga M. Neuroendocrine carcinoma of the liver: an autopsy case. Pathol Int 1998; 48: 481-485.
10. Ayub A, Zafar M, Abdulkareem A, Ali MA, Lingawi T, Harbi A. Primary hepatic VIPoma. Am J Gastroenterol 1993; 88: 958-961.
11. Ferrero A, Gallino C, D'Aloisio G, Gandini G, Garavoglia M. Primary neuroendocrine carcinoma of the liver: difficult diagnosis of a rare neoplasm. Acta Chir Belg 1999; 99: 299-302.
12. Pilichowska M, Kimura N, Ouchi A, Lin H, Mizuno Y, Nagura H. Primary hepatic carcinoid and neuroendocrine carcinoma: clinicopathological and immunohistochemical study of five cases. Pathol Int 1999; 49: 318-324.
13. el Rassi ZS, Ferdinand L, Mohsine RM, Berger F, Lombard-Bohas C, Boillot O et al. Primary and secondary liver endocrine tumors: clinical presentation, surgical approach and outcome. Hepatogastroenterology 2002; 49: 1340-1346.
14. Soga J. Primary hepatic endocrinomas (carcinoids and variant neoplasms). A statistical evaluation of 126 reported cases. J Exp Clin Cancer Res 2002; 21: 457-468.
15. Diaz R, Aparicio J, Pous S, Dolz JF, Calderero V. Primary hepatic gastrinoma. Dig Dis Sci 2003; 48: 1665-1667.
16. Fenwick SW, Wyatt JI, Toogood GJ, Lodge JP. Hepatic resection and transplantation for primary carcinoid tumors of the liver. Ann Surg 2004; 239: 210-219.
17. Giraud S, Zhang CX, Serova-Sinilnikova O, Wautot V, Salandre J, Buisson N et al. Germ-line mutation analysis in patients with multiple endocrine neoplasia type 1 and related disorders. Am J Hum Genet 1998; 63: 455-467.
18. Cai YC, Banner B, Glickman J, Odze RD. Cytokeratin 7 and 20 and thyroid transcription factor 1 can help distinguish pulmonary from gastrointestinal carcinoid and pancreatic endocrine tumors. Hum Pathol 2001; 32: 1087-1093.
19. Solcia E, Klöppel G, Sobin LH in collaboration with nine pathologists from four countries. Histological Typing of Endocrine Tumors (2nd edn). Springer: Berlin, 2000.
20. Wiedenmann B, Jensen RT, Mignon M, Modlin CI, Skogseid B, Doherty G et al. Preoperative diagnosis and surgical management of neuroendocrine gastroenteropancreatic tumors: general recommendations by a consensus workshop. World J Surg 1998; 22: 309-318.
21. Skogseid B. Nonsurgical treatment of advanced malignant neuroendocrine pancreatic tumors and midgut carcinoids. World J Surg 2001; 25: 700-703.
22. Andreola S, Lombardi L, Audisio RA, Mazzaferro V, Koukouras D, Doci R et al. A clinicopathologic study of primary hepatic carcinoid tumors. Cancer 1990; 65: 1211-1218.
23. Sano K, Kosuge T, Yamamoto J, Shimada K, Takayama T, Yamasaki S et al. Primary hepatic carcinoid tumors confirmed with long-term follow-up after resection. Hepatogastroenterology 1999; 46: 2547-2550.
24. Krishnamurthy SC, Dutta V, Pai SA, Kane SV, Jagannath P, Desouza LJ et al. Primary carcinoid tumor of the liver: report of four resected cases including one with gastrin production. J Surg Oncol 1996; 62: 218-221.
25. Norton JA, Doherty GM, Fraker DL, Alexander HR, Doppman JL, Venzon DJ et al. Surgical treatment of localized gastrinoma within the liver: a prospective study. Surgery 1998; 124: 1145-1152.
26. Zimmer T, Stolzel U, Bader M, Koppenhagen K, Hamm B, Buhr H et al. Endoscopic ultrasonography and somatostatin receptor scintigraphy in the preoperative localisation of insulinomas and gastrinomas. Gut 1996; 39: 562-568.
27. Anderson MA, Carpenter S, Thompson NW, Nostrant TT, Elta GH, Scheiman JM. Endoscopic ultrasound is highly accurate and directs management in patients with neuroendocrine tumors of the pancreas. Am J Gastroenterol 2000; 95: 2271-2277.
28. Lebtahi R, Cadiot G, Sarda L, Daou D, Faraggi M, Petegnief Y et al. Clinical impact of somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroenteropancreatic tumors. J Nucl Med 1997; 38: 853-858.
29. 123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 1993; 20: 716-731.
30. Cadiot G, Bonnaud G, Lebtahi R, Sarda L, Ruszniewski P, Le Guludec D et al. Usefulness of somatostatin receptor scintigraphy in the management of patients with Zollinger-Ellison syndrome. Groupe de Recherche et d'Etude du Syndrome de Zollinger-Ellison (GRESZE). Gut 1997; 41: 107-114.
31. McDermott EW, Guduric B, Brennan MF. Prognostic variables in patients with gastrointestinal carcinoid tumours. Br J Surg 1994; 81: 1007-1009.
32. Knox CD, Anderson CD, Lamps LW, Adkins RB, Pinson CW. Long-term survival after resection for primary hepatic carcinoid tumor. Ann Surg Oncol 2003; 10: 1171-1175.
33. Craig JR, Peters RL, Edmondson HA. Tumors of the liver and intrahepatic bile ducts. In Atlas of Tumor Pathology, 2nd series, fascicle 26. Armed Forces Institute of Pathology: Washington, 1989; 102-103.
34. Yang L, Li S, Hatch H, Ahrens K, Cornelius JG, Petersen BE et al. In vitro trans-differentiation of adult hepatic stem cells into pancreatic endocrine hormone-producing cells. Proc Natl Acad Sci USA 2002; 99: 8078-8083.
35. Lehnert T. Liver transplantation for metastatic neuroendocrine carcinoma: an analysis of 103 patients. Transplantation 1998; 66: 1307-1312.
36. Ayoub JP, Hess KR, Abbruzzese MC, Lenzi R, Raber MN, Abbruzzese JL. Unknown primary tumors metastatic to liver. J Clin Oncol 1998; 16: 2105-2112.
37. Elias D, Lasser P, Ducreux M, Duvillard P, Ouellet JF, Dromain C et al. Liver resection (and associated extrahepatic resections) for metastatic well-differentiated endocrine tumors: a 15-year single center prospective study. Surgery 2003; 133: 375-382.
38. Hochwald SN, Zee S, Conlon KC, Colleoni R, Louie O, Brennan MF et al. Prognostic factors in pancreatic endocrine neoplasms: an analysis of 136 cases with a proposal for low-grade and intermediate-grade groups. J Clin Oncol 2002; 20: 2633-2642.